-
1 Comment
Hybio Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 12.2% below its 200 day moving average.
From a valuation standpoint, the stock is 31.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.6.
Hybio Pharmaceutical Co., Ltd's total revenue rose by 133.2% to $247M since the same quarter in the previous year.
Its net income has increased by 105.6% to $9M since the same quarter in the previous year.
Finally, its free cash flow grew by 84.0% to $-53M since the same quarter in the previous year.
Based on the above factors, Hybio Pharmaceutical Co., Ltd gets an overall score of 4/5.
| Industry | Drug Manufacturers - Specialty & Generic |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000011T7 |
| Sector | Healthcare |
| Market Cap | 13B |
|---|---|
| PE Ratio | None |
| Target Price | 15.05 |
| Beta | 0.86 |
| Dividend Yield | None |
Hybio Pharmaceutical Co., Ltd. engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally. It offers liraglutide, semaglutide, and exenatide for diabetes; terlipressin, desmopressin, and linaclotide for digestive tract and metabolic system; ganirelix, cetrorelix, and atosiban for obstetrics and gynecology; customized peptides; working standards for the peptide APIs and related impurities; peptide CRO; and CDMO services, which include peptide API synthesis and purification process development, finish dosage form development, reference standard preparation and qualification, impurity and product quality study and analysis, GMP system meeting EU and FDA standard, international and Chinese regulatory, and dossier support. The company was founded in 1998 and is based in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300199.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
